Key Quantitative Figures - Standalone (Quarter Ended 30-Sep-26)

  • Income from Operations: ₹26,354.13 lakhs
  • Other Income: ₹54.21 lakhs
  • Total Revenue: ₹26,408.34 lakhs
  • Total Expenses: ₹26,307.19 lakhs
  • Profit before tax: ₹101.15 lakhs
  • Tax Expense: ₹38.75 lakhs
  • Net Profit for the period: ₹62.40 lakhs
  • Earnings Per Share (Basic): ₹1.30
  • Earnings Per Share (Diluted): ₹1.30
  • Paid-up Equity Share Capital: ₹481.00 lakhs (Face Value ₹10 each)

Key Quantitative Figures - Standalone (Half Year Ended 30-Sep-26)

  • Income from Operations: ₹47,747.56 lakhs
  • Other Income: ₹103.70 lakhs
  • Total Revenue: ₹47,851.26 lakhs
  • Total Expenses: ₹47,632.74 lakhs
  • Profit before tax: ₹218.52 lakhs
  • Tax Expense: ₹74.54 lakhs
  • Net Profit for the period: ₹143.98 lakhs
  • Earnings Per Share (Basic): ₹2.99
  • Earnings Per Share (Diluted): ₹2.99

Key Quantitative Figures - Consolidated (Quarter Ended 30-Sep-26)

  • Income from Operations: ₹26,354.13 lakhs
  • Other Income: ₹54.21 lakhs
  • Total Revenue: ₹26,408.34 lakhs
  • Total Expenses: ₹26,303.83 lakhs
  • Profit before tax: ₹104.51 lakhs
  • Tax Expense: ₹39.52 lakhs
  • Net Profit for the period: ₹64.99 lakhs
  • Earnings Per Share (Basic): ₹1.35
  • Earnings Per Share (Diluted): ₹1.35

Key Quantitative Figures - Consolidated (Half Year Ended 30-Sep-26)

  • Income from Operations: ₹47,747.56 lakhs
  • Other Income: ₹103.70 lakhs
  • Total Revenue: ₹47,851.26 lakhs
  • Total Expenses: ₹47,626.89 lakhs
  • Profit before tax: ₹224.38 lakhs
  • Tax Expense: ₹75.88 lakhs
  • Net Profit for the period: ₹148.50 lakhs
  • Earnings Per Share (Basic): ₹3.09
  • Earnings Per Share (Diluted): ₹3.09

Balance Sheet Highlights (Standalone as of 30-Sep-26)

  • Total Assets: ₹23,313.36 lakhs
  • Non-current assets: ₹2,781.89 lakhs
  • Current assets: ₹20,531.47 lakhs
  • Inventories: ₹17,456.70 lakhs
  • Trade receivables: ₹2,492.71 lakhs
  • Cash and cash equivalents: ₹163.57 lakhs
  • Total Equity: ₹5,824.87 lakhs
  • Non-current liabilities: ₹1,446.86 lakhs
  • Current liabilities: ₹16,041.63 lakhs
  • Borrowings: ₹5,548.12 lakhs (current) + ₹1,235.20 lakhs (non-current)

Cash Flow Statement (Standalone H1 FY27)

  • Net cash flow from operating activities: (₹982.03) lakhs
  • Net cash flow from investing activity: (₹89.96) lakhs
  • Net cash flow from financing activity: ₹1,118.61 lakhs
  • Net increase in cash & cash equivalent: ₹46.62 lakhs
  • Cash & cash equivalent at beginning: ₹116.95 lakhs
  • Cash & cash equivalent at end: ₹163.57 lakhs

Subsidiary Information

  • The consolidated financial statement includes subsidiary Puregene Biotech Limited (CIN: U01222MP1999PLC013303)
  • Puregene Biotech contributed total revenue of ₹13.50 lakhs for Q2 FY27 and ₹27.00 lakhs for H1 FY27
  • Puregene Biotech net profit after tax was ₹2.59 lakhs for Q2 FY27 and ₹4.52 lakhs for H1 FY27

Additional Information

  • No exceptional items or prior period items reported
  • No discontinuing operations
  • The company is primarily engaged in Poultry Breeding & Farming activities only
  • No identifiable operating segments under IND AS-108
  • Meeting commenced at 5:00 PM and concluded at 7:00 PM on 14th November, 2026
  • Results to be published in Hindi and English newspapers with QR code
  • Results to be uploaded on company website (www.simranfarms.com) and BSE website

Auditor's Review

  • Khandelwal Kakani & Company conducted limited review of both standalone and consolidated results
  • Review performed under SRE 2410 issued by ICAI
  • Auditors concluded nothing came to their attention suggesting material misstatement
  • UDIN for standalone review: 26070546WNYPMM6154
  • UDIN for consolidated review: 26070546ABMNTF8090